Home / Generics / Research / Reasons for the success of a generics company in the Sudan market

Reasons for the success of a generics company in the Sudan market Posted 24/06/2016

An exploratory, qualitative study carried out by colleagues from the University of Khartoum (Sudan) and Abertay University (UK) examined the reasons behind the success of a generics company that has been the market leader in Sudan for a decade from the perspective of employees and customers [1].

In February 2014, three different focus groups were conducted, including company employees, purchasers and prescribers. Each focus group was recorded, transcribed and coded into themes. Thematic analysis was carried out. Participants were coded using the letter P followed by a number.

The study revealed that differentiation was a successful strategy for the generics company. The most important differentiation aspect was the quality of the products. Prescribers identified that the high quality products were the fundamental reason that made them prescribe company products:

‘I prescribe its products because of their high quality and effectiveness’ (P8)

Another key aspect of the company’s success and differentiation in Sudan, which was identified by employees, was the intense branding activities:

‘I think branding was the most important factor behind our success in Sudan in the last 10 years’ (P4)

Employees also highlighted that high product quality helped them be differentiated from other generics companies and was an important reason behind success. While the high quality of the employees was also reported to differentiate them:

‘The company employees are respectful, professional and decent’ (P8)

Excellent customer service was also found to contribute to the company’s performance:

‘The company has an excellent customer service. They used to provide us with free samples whenever we asked them’ (P8)

Employees mentioned that the friendly company culture was an important factor behind its success:

‘The company had a family environment’ (P4)

Some employees believed that management leadership played an important role in the company’s success:

‘For me, leadership had an effect on our success’ (P7)

The study revealed that the quality of drugs is the main concern for healthcare professionals. This result is consistent with previous research that found ‘when customers use a particular brand frequently, they use their past experience about that brand regarding performance, quality and aesthetic appeal’. The company was also found to have excellent customer service. Previous research has also found that organizations that focus on their customers consistently outperform their rivals.

The three focus groups highlighted that the professionalism of the medical representatives was one of the key reasons behind its success. Intense promotion, rather than price leadership, was identified as a key success factor of the differentiation strategy adopted by the company. It has been argued that firms’ financial success depends on their marketing abilities.

Employees identified that leadership played a role in the company success. Research over the past two decades has shown that changes in leadership are followed by changes in firms’ performance. Employees described a friendly and competitive organization climate as one of the key factors behind success. A direct correlation has been found between organization climate and financial results.

Most of the participants thought that the company success is sustainable in the future. The portfolio and expansion of geographic coverage were considered as the main drivers for success.

The study concluded that differentiation is an important strategy for the success of generics companies.

Conflict of interest
The author of the research paper [1] did not provide any conflict of interest statement.

Abstracted by Anas Mustafa Ahmed Salim, Lecturer, Faculty of Pharmacy, University of Khartoum, Sudan.

Editor’s comment
Readers interested to learn more about generics markets are invited to visit www.gabi-journal.net to view the following manuscript published in GaBI Journal:

Promoting a competitive generics market in the US

GaBI Journal is now indexed in Embase, Scopus, Thomson Reuters’ ESCI, and more

Readers interested in contributing a research or perspective paper to GaBI Journal – an independent, peer reviewed academic journal platform – please send us your submission here.

Related articles
Obama budget aims to increase use of generics and biosimilars

Generics makers to be penalized for huge price hikes

Reference
1. Ahmed Salim AM, Mulholland G. Examining the reasons behind the success of the generic pharmaceutical companies: the case of Sudan market. Middle East J Business. 2015;10(4):59-64.

Permission granted to reproduce for personal and non-commercial use only. All other reproduction, copy or reprinting of all or part of any ‘Content’ found on this website is strictly prohibited without the prior consent of the publisher. Contact the publisher to obtain permission before redistributing.

Copyright – Unless otherwise stated all contents of this website are © 2016 Pro Pharma Communications International. All Rights Reserved.

Comments (0)

Generics News Research General

more

Biosimilars News Research General

more